Accenture Invests In 1910 Genetics To Expedite AI-based Drug Discovery
Acn) has invested, through accenture ventures, in 1910 genetics (or “1910”), a. Acn) has invested, through accenture ventures, in 1910 genetics (or “1910”), a biotechnology company. “we are thrilled to be collaborating with 1910 genetics to bring their pioneering ai drug discovery engines to azure quantum elements,” said jason zander, executive vice president of. Acn) has invested, through accenture ventures , in 1910 genetics (or “1910”), a biotechnology company advancing small and large molecule drug. Accenture ventures, the venture capital arm of accenture, has invested in 1910 genetics, a biotechnology company focused on drug discovery using a multimodal artificial.